Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3528541010 | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | en | Definition | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
3509107010 | Enzyme inhibitor (disposition) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3509108017 | Enzyme inhibitor | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Is a | A substance that alters biochemical processes in a cell by decreasing or increasing the activity of an enzyme. | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
5-lipoxygenase inhibitor (disposition) | Is a | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Alcohol dehydrogenase inhibitor (disposition) | Is a | False | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Transferase inhibitor (disposition) | Is a | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Topoisomerase inhibitor (disposition) | Is a | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Xanthine oxidase inhibitor (disposition) | Is a | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
C1 esterase inhibitor (disposition) | Is a | False | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Angiotensin-converting enzyme inhibitor (disposition) | Is a | False | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Aromatase inhibitor (disposition) | Is a | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Carbonic anhydrase inhibitor (disposition) | Is a | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Cyclooxygenase-2 inhibitor | Is a | False | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
HMG-CoA reductase inhibitor | Is a | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Kallikrein inhibitor (disposition) | Is a | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Lipase inhibitor (disposition) | Is a | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Monoamine oxidase inhibitor (disposition) | Is a | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Hydrolase inhibitor (disposition) | Is a | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Protease inhibitor (disposition) | Is a | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Dihydroxyphenylalanine decarboxylase inhibitor (disposition) | Is a | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
C1q esterase inhibitor (disposition) | Is a | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
5-alpha reductase inhibitor (disposition) | Is a | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Inter-alpha-trypsin inhibitor (disposition) | Is a | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Plasmin inhibitor (disposition) | Is a | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Plasminogen activator inhibitor (disposition) | Is a | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Protease inhibitor protein (disposition) | Is a | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Acetylcholinesterase inhibitor (disposition) | Is a | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Cytochrome P450 inhibitor (disposition) | Is a | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Tryptophan hydroxylase inhibitor (disposition) | Is a | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Protein secretory trypsin inhibitor | This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. | False | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Beta-galactosidase-alpha-neuraminidase-protective protein (substance) | This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Alpha-1-antichymotrypsin | This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Antichymotrypsin | This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Enzyme inhibitor protein | This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Nitisinone (substance) | This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. | False | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Enzyme inhibitor | This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Racecadotril | This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Gimeracil (substance) | This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Sacubitril (substance) | This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. | False | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Tavaborole (substance) | This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. | False | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Dehydrogenase inhibitor (disposition) | Is a | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Cytomegalovirus terminase complex inhibitor | Is a | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Coagulation factor Xa inhibitor | Is a | False | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Beta-lactamase inhibitor | Is a | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Mizoribine | This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Ribonucleoside-diphosphate reductase inhibitor (disposition) | Is a | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Tyrosine 3-monooxygenase inhibitor (disposition) | Is a | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
NAD(P)H dehydrogenase (quinone) inhibitor | Is a | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Non-chaperonin molecular chaperone ATPase inhibitor (disposition) | Is a | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Prostaglandin-endoperoxide synthase inhibitor (disposition) | Is a | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Oxidoreductase inhibitor (disposition) | Is a | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Ecadotril | This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. | False | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Protein synthase inhibitor (disposition) | Is a | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Renin-angiotensin system inhibitor | Is a | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some | |
Hypoxia-inducible factor-proline dioxygenase inhibitor (disposition) | Is a | True | Compound or agent that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction US Library of Medicine MESH Descriptor data Accessed 20/01/2017 | Inferred relationship | Some |
This concept is not in any reference sets